Novavax says it could start making Omicron-specific vaccine in January
Go back to Novavax says it could start making Omicron-specific vaccine in January| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.66 +0.03 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.63 | 52 Week High | $9.23 | |||
| Open | $10.50 | 52 Week Low | $1.16 | |||
| Day High | $10.98 | P/E | N/A | |||
| Day Low | $10.26 | EPS | $-0.30 | |||
| Volume | 3,433,588 | |||||
